Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia - Wikidata - wikimedia - TriplyDB

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

http://www.wikidata.org/entity/Q24202503

about

Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour 'There and back again': revisiting the pathophysiological roles of human endogenous retroviruses in the post-genomic era BRD4 inhibitor inhibits colorectal cancer growth and metastasis.Endometrial carcinoma with yolk sac tumor-like differentiation and elevated serum β-hCG: a case report and literature review.Late spontaneous resolution of persistent molar pregnancy.Incidence of gestational trophoblastic disease in Tokat province, Turkey.Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease.

P2860

Q24201759-787CA82E-AA32-437A-B619-541E9A20BF25 Q24289157-086D84F5-0D2C-4BCC-B02B-EB6FEF234827 Q35016695-6C715A86-A0CD-4C9D-9EC6-8E6DF3B5FB04 Q37260967-B9F979ED-336A-43DC-BB02-97447EC9300D Q38698766-F8BDAF6A-98DF-4B31-B870-8D547DFB5AC8 Q39047381-598750C4-7557-4BF5-B7D5-FD6F22CFDA5A Q39513852-6ECE95FC-ABAE-497F-8784-6205E8A7D217 Q42540880-7CF4A140-B107-46BB-973D-5CA79CBBF058

P2860

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

http://www.wikidata.org/entity/Q24202503

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@ast

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@en

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@en-gb

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@nl

type

label

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@ast

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@en

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@en-gb

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@nl

prefLabel

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@ast

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@en

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@en-gb

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@nl

P1433

Q24202503-5C33AFD8-7D2E-4C47-B15F-C757AA536A69

P1476

Q24202503-7103391C-6276-4DD5-AAFA-45F50A345C41

P2093

Q24202503-0875276D-674A-4687-BE5C-61B554910D30

Q24202503-BAD522FD-2210-4108-B2D0-F2D180FAAF99

Q24202503-BEBA7AC5-7332-41C0-A9CB-821F96B24A98

Q24202503-F6EC9107-38A5-4457-804B-D7FA2C97E35A

P2860

Q24202503-056592E1-E2F5-49B6-8BA9-08D3A6DE077C

Q24202503-09D88EBC-7A82-473B-87FD-987A9F844414

Q24202503-11294ADD-CB7C-4C12-BF9E-D721E9AA0AB0

Q24202503-175C851B-6356-4BF1-BA46-B398507CAA02

Q24202503-2FD43B99-E044-4BAD-86C7-6C06548CB460

Q24202503-3B32FDDE-F325-47AC-8445-0DB8AA42D153

Q24202503-3E51820B-03D1-460F-B1B6-3FCA4C499798

Q24202503-46F40BEC-CC47-4101-AD01-E4380E1EBCEE

Q24202503-51817124-C95F-471E-A5B6-54A076A463EF

Q24202503-54477E86-0CCC-45D2-A1F5-4926D59ACA5B

P304

Q24202503-8E40C2CA-43CC-4AA0-ACBB-1291DBB2A779

P31

Q24202503-7E145257-A9FF-47F5-92F6-ED9AEE1F8746

P356

Q24202503-163ABDA0-3AC3-458E-9F3F-E229BC43AB7D

P478

Q24202503-22A5CF37-B249-4F53-8A78-DB13A2405254

P50

Q24202503-B2579C71-9281-4E98-A936-B09ADAE721FA

Q24202503-E9B9989C-F58E-4DBD-9929-0BABFD4A7AB3

P577

Q24202503-21FCE7CA-2A97-4F86-B374-E4C8C818717E

P698

Q24202503-B48E15F8-1747-4F1D-ADD0-8E410D8B264A

P921

Q24202503-093AD38E-ED1A-4883-A5D7-7686553AC1CD

P356

14651858.CD008891.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

@en

P2093

Barry W Hancock

http://www.w3.org/2001/XMLSchema#string

John Tidy

http://www.w3.org/2001/XMLSchema#string

Raymond Osborne

http://www.w3.org/2001/XMLSchema#string

Robert Coleman

http://www.w3.org/2001/XMLSchema#string

P2860

Combination chemotherapy for high-risk gestational trophoblastic tumour

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Meta-analysis in clinical trials

Salvage combination chemotherapy with 5-fluorouracil and actinomycin D for patients with refractory, high-risk gestational trophoblastic tumors.

Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects

EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II-IV).

Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.

Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.

The management and outcome of women with post-hydatidiform mole 'low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1).

Treating gestational trophoblastic disease.

P304

CD008891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD008891.PUB2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Theresa A Lawrie

P577

2012-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23235667

http://www.w3.org/2001/XMLSchema#string

P921